Related Experiment Video
Updated: Feb 19, 2026
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Wls Expression Correlates with Tumor Differentiation and TNM Stage in Hepatocellular Carcinoma
Chao Zhou1, Yuejun Sun2, Shuwei Guo3
1Department of Infection, Danyang People's Hospital of Jiangsu Province, No.2 Xinmin Xi Lu, Dan Yang, Jiangsu, China.
Background:
Hepatocellular carcinoma (HCC) is an aggressive cancer with a poor prognosis. Effective biomarkers are necessary to predict the clinical course and outcome of patients with HCC. Wntless (Wls) is a key modulator of Wnt protein secretion and is overexpressed in various human cancers. However, the mechanism and alteration of Wls expression in HCC have not been clarified.
Aims:
The aim of this study was to evaluate expression level of Wls in HCC and its clinical significance.
Methods:
The levels of Wls expression were investigated in 84 HCC tissues using immunohistochemistry.
Results:
Wls was negatively expressed in normal liver tissue and was negatively or weakly (score 0) expressed in liver cirrhosis. Twenty-eight out of 84 samples (33.3%) were negative or weakly (score 0) expressed Wls, 38 out of 84 (45.2%) moderately (1+) expressed Wls, and 18 out of 84 (21.4%) strongly (2+) expressed Wls. Wls expression was positively associated with tumor size (P = 0.005, r = 0.302), tumor TNM stage (P = 0.017, r = 0.261), AFP (P = 0.051), and HBV infection (P = 0.009, r = 0.283), and was negatively associated with differentiation (P < 0.001, r = - 0.552). No significant relationship between Wls expression and liver cirrhosis, ALT, GGT, age, sex, or tumor focality was found.
Conclusions:
Our data showed that Wls was differentially expressed in HCC. Statistical analysis results suggest that Wls expression might increase as HCC progresses.
